D-Wave Quantum (QBTS) — Company Research
Last Updated: 27 May 2026
D-Wave Quantum Inc. (NYSE: QBTS) is one of the only commercial pure-play quantum computing companies in the world, and the clear leader in annealing-based quantum systems — a specialised approach optimised for solving very large optimisation, scheduling and AI problems. In 2025 the company moved from a research curiosity to a credible commercial business: full-year revenue of $24.6 million (up 179%), a landmark $20 million system sale to Florida Atlantic University, the industry’s first $10 million enterprise quantum-computing-as-a-service deal, and over $635 million of cash on the balance sheet. In May 2026 it signed a Letter of Intent with the U.S. Department of Commerce for up to $100 million in CHIPS Act funding, an explicit endorsement of its annealing and newly acquired gate-model roadmap.
1. Company Snapshot
| Field | Value |
|---|---|
| Ticker | QBTS (NYSE) |
| Headquarters | Palo Alto, California (operations centre in Burnaby, British Columbia, Canada) |
| CEO / Leadership | Dr. Alan Baratz (Chief Executive Officer since January 2020) |
| Employees | Approximately 220 full-time employees (April 2026) |
| Sector | Information Technology — Quantum Computing |
| FY2025 Revenue | $24.6m (+179% YoY) |
| FY2025 Net Loss (GAAP) | $(355.1)m (includes $270.5m non-cash warrant remeasurement) |
| Cash & marketable securities (Q1 2026) | $588.4m |
| Market Cap (27 May 2026) | Approximately $10.9bn |
| Last earnings report | Q1 2026 reported 12 May 2026 |
D-Wave is unique among quoted quantum names in that it has been selling working quantum systems and cloud access to paying enterprise customers since 2011. CEO Alan Baratz, a former JavaSoft and Cisco executive with a computer-science doctorate from MIT, has steered the business toward a commercial-first model: real systems delivered to paying customers, rather than research-grant-only revenue.
2. Bull & Bear
Bull Case
- Only commercial annealing pure-play: D-Wave is the only company shipping production annealing quantum computers, a structurally different and more mature niche than the gate-model race chased by IBM, Google, IonQ and Rigetti.
- Bookings inflection is real: Q1 2026 bookings of $33.4m were up nearly 2,000% year-on-year and 149% sequentially over a strong Q4 2025, signalling that the FY2025 revenue jump was not a one-off.
- Cash runway measured in years, not quarters: $588m of cash and marketable securities at 31 March 2026 funds the business well beyond the current cash burn rate even after the Quantum Circuits acquisition.
- Government endorsement: The May 2026 Letter of Intent with the U.S. Department of Commerce for $100m of CHIPS Act funding is a meaningful sovereign endorsement and validates the commercial roadmap.
- Gate-model optionality: The Quantum Circuits acquisition (closed early 2026, $550m) gives D-Wave a credible gate-model story alongside annealing, addressing the historic bear point that annealing alone is too narrow.
Bear Case
- Valuation disconnected from current revenue: A market cap near $10.9bn on $24.6m of FY2025 revenue puts the price-to-sales ratio above 400x — pricing in near-perfect execution of a still-speculative end-market.
- Cash burn is structural: FY2025 free cash flow was approximately -$75.8m and Q1 2026 adjusted EBITDA loss was $32.8m; even with a long runway, every quarter of dilution risk is real until the business reaches breakeven.
- Revenue is lumpy: Q1 2026 revenue fell 81% year-on-year on the absence of a single large system sale, demonstrating the company is still dependent on a handful of large deals each quarter.
- Annealing has real technical limits: Annealing is best for optimisation, but the broader market opportunity (quantum advantage in chemistry, materials, ML) is gate-model territory where D-Wave is a late entrant via acquisition.
- Quantum competition is intensifying: IBM (~$237bn market cap with $1bn government grant) and IonQ (~$21bn market cap, $130m+ revenue) are larger, better-funded competitors; consolidation pressure is rising.
3. Business Segments
D-Wave does not yet split its results into reportable operating segments, but the revenue base can be characterised by product line and end market.
| Segment | % of FY2025 revenue (estimate) | What it is |
|---|---|---|
| System sales | ~70% | Sale of complete on-premises Advantage2 annealing quantum computers to government, university and enterprise customers (e.g. $20m Florida Atlantic University sale in January 2026). |
| Quantum Computing as a Service (QCaaS) | ~25% | Cloud access to D-Wave annealing and hybrid systems via the Leap real-time quantum cloud service and through partners including AWS Braket. Includes large multi-year enterprise licences (e.g. the $10m enterprise QCaaS deal signed January 2026). |
| Professional services | ~5% | Consulting, problem mapping and application development services attached to system and QCaaS contracts; primarily a customer-success function rather than a margin driver. |
Geographically, the U.S. is the largest market, supported by federal agency contracts and growing university adoption; international revenue comes from Japan, Germany and the U.K. The Quantum Circuits acquisition will, in time, introduce a fourth revenue line from gate-model hardware.
4. Business Model & Moat
How it makes money. Three distinct revenue pillars: outright system sales (multi-million-dollar ticket, recognised on delivery), cloud subscription access to D-Wave hardware via Leap (recurring), and professional services attached to both. Gross margins are unusually high for a hardware business — FY2025 GAAP gross margin was 83% — because once a system is built, incremental cloud access is essentially software economics.
The moat. D-Wave’s competitive position rests on three pillars. First, it has been refining annealing-specific hardware for more than a decade; replicating that institutional knowledge would require a multi-year, multi-hundred-million-dollar investment by any new entrant. Second, the customer base is sticky: enterprise quantum projects involve months of problem mapping and joint development, which raises switching costs. Third, the workforce includes a concentration of experienced quantum-hardware engineers in Burnaby, BC, that is difficult to replicate elsewhere.
Where the moat is thin. The biggest gap is that the broader gate-model race — arguably the larger long-term opportunity — was being run without D-Wave until the Quantum Circuits acquisition. The company is now playing catch-up in gate hardware against IBM, Google, IonQ and Rigetti, each of whom has a multi-year head start.
5. Financial Health
D-Wave is still a small-revenue, cash-consuming company in the early commercialisation phase of a deep-tech market. The pattern is rapid percentage revenue growth from a low base, large GAAP net losses that are amplified by non-cash warrant-fair-value movements, and a very heavily funded balance sheet from successive equity raises.
| Year | Revenue ($m) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt YE ($m) |
|---|---|---|---|---|---|---|
| FY2021 | 6.1 | n/a | n/a (pre-IPO) | n/a | Nil | 11.4 |
| FY2022 | 7.0 | +14% | $(0.50) | $(0.46) | Nil | 13.8 |
| FY2023 | 8.8 | +25% | $(0.59) | $(0.47) | Nil | 40.8 |
| FY2024 | 8.8 | +0.8% | $(0.81) | $(0.51) | Nil | 44.3 |
| FY2025 | 24.6 | +179% | $(1.42) | $(0.31) | Nil | 35.8 |
Quarterly revenue is lumpy — large system sales are recognised on delivery and a single $15m system sale in Q1 2025 distorted the year-on-year comparison for Q1 2026.
| Quarter | Revenue ($m) | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| Q1 2026 | 2.9 | $(0.10) | $(0.06) |
| Q4 2025 | 2.75 | $(0.07) | $(0.21) |
| Q3 2025 | 3.7 | $(0.08) | $(0.08) |
| Q2 2025 | 3.1 | $(0.06) | $(0.07) |
| Q1 2025 | 15.0 | $(0.02) | $(0.08) |
| FY2025 total | 24.6 | $(0.31) | $(1.42) |
Cash and marketable securities ended Q1 2026 at $588.4m, up 93% year-on-year even after roughly $250.8m of Quantum Circuits acquisition spending. Long-term debt is modest at around $35.8m as of year-end 2025 — mostly financing leases and equipment loans rather than corporate term debt.
6. Valuation
Raw metrics, May 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Market cap | ~$10.9bn (27 May 2026, share price ~$29.40) |
| Enterprise value | ~$10.3bn (market cap ~$10.9bn + total debt ~$36m − cash & marketable securities ~$588m, per Q1 2026 balance sheet) |
| Trailing P/E (GAAP) | Not meaningful (FY2025 GAAP net loss of $355m) |
| P/E (forward) | Not meaningful (consensus forecasts continued GAAP losses for FY2026) |
| P/S (TTM) | ~442x (market cap ~$10.9bn / TTM revenue ~$24.6m) |
| EV/EBITDA (TTM) | Not meaningful (FY2025 adjusted EBITDA loss; GAAP operating loss large and negative) |
| P/FCF | Not meaningful (FCF negative; market cap ~$10.9bn / FCF -$75.8m FY2025; FCF = operating cash flow -$71.9m − capex $3.9m per FY2025 cash flow statement) |
| 52-week high | $46.75 |
| 52-week low | $12.75 |
| Short interest (% of float) | 14.5% (50.0m+ shares short, MarketBeat May 2026) |
| Days to cover | 1.9 |
The valuation is best understood as an option on a future, much larger quantum computing market. Conventional earnings or cash-flow multiples produce non-meaningful outputs at this stage of the business; the price-to-sales ratio of over 400x is consistent with very long-duration growth assumptions.
7. Growth Drivers
Enterprise QCaaS adoption. The first $10m enterprise QCaaS contract signed in January 2026 is a template the company aims to replicate. Each enterprise contract carries multi-year, recurring economics and is more valuable than a one-off system sale because it builds an annualised revenue base.
Two-to-three system sales per year. Management guided on the Q1 2026 call to 2–3 quantum system deliveries per year, each potentially $15–25m in revenue. This alone could lift annual revenue to $30–75m before any QCaaS or services growth.
Federal funding tailwind. The $100m CHIPS Act LOI, the U.S. National Quantum Initiative reauthorisation and the broader $2bn federal quantum investment programme are creating a sustained pipeline of government-funded research and procurement opportunities for U.S.-based quantum companies.
Gate-model entry via Quantum Circuits. The acquisition gives D-Wave access to the larger gate-model market opportunity and a pathway into chemistry, materials and machine-learning applications that were previously out of reach for an annealing-only company.
Hybrid quantum-classical workloads. D-Wave’s Leap service increasingly markets hybrid solvers that combine classical and quantum compute — lowering the barrier to entry for customers and expanding the addressable use cases.
8. Peer Comparison
| Peer | Market cap (May 2026) | Key 2025 metric |
|---|---|---|
| IonQ (IONQ) | ~$21bn | FY2025 revenue ~$130m; FY2026 guidance $225–245m |
| Rigetti Computing (RGTI) | ~$8.8bn | FY2025 revenue $7.1m (−34% YoY); cash $569m, no debt |
| D-Wave Quantum (QBTS) | ~$10.9bn | FY2025 revenue $24.6m (+179% YoY); cash $588m |
| IBM (IBM) | ~$238bn | $1bn cumulative quantum business booked; quantum is a small but strategic part of an enterprise services giant |
| Quantum Computing Inc. (QUBT) | ~$2.4bn (May 2026) | FY2025 revenue <$1m; smaller, photonics-focused pure-play |
Among the pure-plays, D-Wave is the revenue leader on absolute scale of commercial deployments, but IonQ is the revenue leader on top-line growth and total dollar revenue. IBM dwarfs the entire pure-play category in resources but is not a pure-play investment vehicle for quantum.
9. Insider Activity
Recent insider activity is dominated by routine compensation events (RSU vesting and 10b5-1 plan sales) rather than open-market discretionary buying or selling.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| Diane Nguyen (EVP & Chief Legal Officer) | 21 May 2026 | Sale | 40,000 | $25.014 (wt. avg) | ~$1.00m | Rule 10b5-1 (adopted Aug 2025) |
| Diane Nguyen (EVP & Chief Legal Officer) | 14 May 2026 | Tax withholding on RSU vest | 2,459 | n/a | n/a | Vesting-related |
| Alan E. Baratz (President & CEO) | 30 Apr 2026 | RSU grant | 753,941 | n/a | n/a | Quarterly vesting through Jan 2030 |
| Sophie C. Ames (EVP) | 15 Apr 2026 | Sale | 3,070 | $21.3513 (wt. avg) | ~$66k | Rule 10b5-1 |
The CEO’s 753,941 RSU grant is the largest recent transaction and is a multi-year retention award rather than open-market buying. The 10b5-1 plan sales by other executives are scheduled, pre-committed disposals and should not be read as discretionary signalling.
10. Key Risks
- Commercial-traction risk: Quantum advantage — performing a useful task on a quantum computer that a classical computer cannot — remains unproven at scale outside of narrow benchmark problems. Enterprise customers may delay or cancel programmes if real-world ROI does not appear.
- Cash burn and dilution risk: While the runway is multi-year, continued losses mean further equity raises are possible if the path to breakeven extends; new share issuance dilutes existing holders.
- Technology disruption risk: Breakthroughs in gate-model fault tolerance, photonic quantum or neutral-atom architectures could marginalise annealing as a commercial approach.
- Customer concentration risk: A small number of large enterprise and government contracts drive a meaningful share of revenue in any given quarter; loss or delay of one contract can significantly affect quarterly results.
- Acquisition-integration risk: The $550m Quantum Circuits acquisition is unusually large relative to D-Wave’s history; integrating gate-model engineering culture, retaining talent and avoiding scope drift are non-trivial.
- Regulatory and export-control risk: Quantum technology is increasingly being treated as a strategic dual-use technology; new U.S. or allied export restrictions could constrain sales to foreign customers.
- Macro and capital-markets risk: Long-duration loss-making technology stocks are highly sensitive to interest-rate expectations and risk-on/risk-off market regimes.
11. Recent Developments
- 26 May 2026 — D-Wave signs $100m CHIPS Act Letter of Intent. The company announced a Letter of Intent with the U.S. Department of Commerce for $100m of proposed CHIPS and Science Act funding. In exchange, D-Wave would issue $100m of common stock to the Department of Commerce. The funding is earmarked for scaling annealing and gate-model systems and expanding R&D facilities in Florida, Connecticut and Canada.
- 12 May 2026 — Q1 2026 results. Reported revenue of $2.9m (down 81% on a tough Q1 2025 comparison that included a $15m system sale), bookings of $33.4m (up nearly 2,000% YoY), net loss of $18.4m, and ending cash and marketable securities of $588.4m. Adjusted EBITDA loss was $32.8m.
- April 2026 — CEO RSU grant. CEO Alan Baratz was granted 753,941 RSUs vesting quarterly through January 2030, a multi-year retention award.
- Q1 2026 — Quantum Circuits acquisition closed. D-Wave closed the $550m acquisition of gate-model quantum specialist Quantum Circuits, adding gate-model hardware to its annealing roadmap.
- January 2026 — Two landmark sales. A $20m on-premises Advantage2 system sale to Florida Atlantic University, plus the industry’s first $10m enterprise quantum-computing-as-a-service deal.
- March 2026 — Full-year 2025 results. Full-year revenue of $24.6m (+179% YoY), GAAP gross profit $20.3m at 83% margin, ending liquidity over $884m, GAAP net loss of $355.1m largely from a $270.5m non-cash warrant remeasurement charge.
12. Key Dates
- 6 Aug 2026 — Q2 2026 earnings release (anticipated, based on prior-period cadence)
- 30 Sep 2026 — Target for first two Quantum Circuits-derived gate-model demonstrations (per CEO commentary on Q1 2026 call)
- 31 Dec 2026 — Expected delivery of at least two on-premises quantum systems per management guidance of 2–3 system deals per year
- 11 Mar 2027 — Anticipated FY2026 full-year earnings release
Investors interested in tracking the technical setup intraday can view live charts on the ChartsView Live Charts page, monitor major macro releases on the Economic Calendar, and join the community discussion on the ChartsView Forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.
Loading research report…
13. Thesis Verdict
The central thesis. D-Wave Quantum is the only commercial pure-play quantum company shipping production annealing systems and cloud access to enterprise customers, with three revenue pillars — outright system sales, Leap quantum-cloud subscriptions, and attached services. FY2025 revenue rose 179% to $24.6 million on an 83% GAAP gross margin, alongside a $355m GAAP net loss that was inflated by a $270m non-cash warrant remeasurement. Management has guided to 2–3 system deliveries per year and recently signed two landmark January 2026 deals worth $30m combined. The May 2026 $100m CHIPS Act Letter of Intent is the most important near-term catalyst alongside the Q2 2026 earnings print.
What would confirm or break it. Sustained quarterly bookings above $30m, two completed system deliveries during 2026 and evidence of recurring QCaaS revenue growth would confirm the commercial-traction thesis. The thesis breaks if quantum-advantage demonstrations fail to translate into enterprise ROI, if cash burn forces further dilutive equity raises before breakeven, or if larger gate-model rivals (IBM, Google, IonQ) marginalise annealing as a commercial approach.
Watchpoints
- ConfirmsQ2 2026 earnings (71 days) landing in line with or above management guidance.
- ConfirmsEvidence supporting the "Only commercial annealing pure-play:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "Commercial-traction risk:" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 27 May 2026.
